16-4340323-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000318059.8(PAM16):c.374C>T(p.Thr125Met) variant causes a missense change. The variant allele was found at a frequency of 0.000189 in 1,612,472 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T125T) has been classified as Likely benign.
Frequency
Consequence
ENST00000318059.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAM16 | NM_016069.11 | c.374C>T | p.Thr125Met | missense_variant | 5/5 | ENST00000318059.8 | NP_057153.8 | |
CORO7-PAM16 | NM_001201479.2 | c.3143C>T | p.Thr1048Met | missense_variant | 31/31 | NP_001188408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAM16 | ENST00000318059.8 | c.374C>T | p.Thr125Met | missense_variant | 5/5 | 1 | NM_016069.11 | ENSP00000315693 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000224 AC: 56AN: 249756Hom.: 1 AF XY: 0.000214 AC XY: 29AN XY: 135524
GnomAD4 exome AF: 0.000187 AC: 273AN: 1460184Hom.: 1 Cov.: 32 AF XY: 0.000169 AC XY: 123AN XY: 726312
GnomAD4 genome AF: 0.000204 AC: 31AN: 152288Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2021 | The c.3143C>T (p.T1048M) alteration is located in exon 31 (coding exon 31) of the CORO7-PAM16 gene. This alteration results from a C to T substitution at nucleotide position 3143, causing the threonine (T) at amino acid position 1048 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2022 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 125 of the PAM16 protein (p.Thr125Met). This variant is present in population databases (rs148571756, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with PAM16-related conditions. ClinVar contains an entry for this variant (Variation ID: 1494233). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at